Fact CheckerSign in

NCT07127107Not yet recruiting

Effect of Manual Therapy on Migraine in Postmenopausal Women

Source: ClinicalTrials.gov · Last updated 17 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of the study is to determine the effect of manual therapy on migraine in postmenopausal women.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
11 Aug 2025
Start date
20 Aug 2025
Primary completion date
20 Feb 2026
Lead sponsor
Cairo University
Diseases
Migraine
NCT number
NCT07127107

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 20 Aug 2025 to the primary completion date, 20 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Hormonal replacement therapy.

Other illness

  • Acute intracerebral bleeding.

Other

  • Artificial or premature menopause
  • Recent head trauma.
  • Cerebral aneurysm or rupture.
  • Tumors.

Who the study is looking for

  • All women are postmenopausal at least one year following last menstruation.
  • They are suffering from migraine.
  • Their ages will range from 50 to 60 years old.
  • Their body mass index (BMI) will not exceed 30 Kg/m2.
  • Women with regular or irregular attacks of migraine.

Age in the registry: 50 years to 60 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Marwa Mohamed Mohamed Yassen
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.